BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 8218489)

  • 1. Biologic and molecular characterization of non-Hodgkin's lymphoma.
    Gaidano G; Dalla-Favera R
    Curr Opin Oncol; 1993 Sep; 5(5):776-84. PubMed ID: 8218489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biology of the lymphomas: cytogenetics, molecular biology, and virology.
    Ambinder RF; Griffin CA
    Curr Opin Oncol; 1991 Oct; 3(5):806-12. PubMed ID: 1661167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologic aspects of AIDS-associated non-Hodgkin's lymphoma.
    Knowles DM
    Curr Opin Oncol; 1993 Sep; 5(5):845-51. PubMed ID: 8218497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular pathogenesis of non-Hodgkin lymphoma: a clinical perspective.
    Gaidano G; Pastore C; Volpe G
    Haematologica; 1995; 80(5):454-72. PubMed ID: 8566891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
    Matolcsy A; Chadburn A; Knowles DM
    Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential bcl-2 and c-myc oncogene rearrangements associated with the clinical transformation of non-Hodgkin's lymphoma.
    Lee JT; Innes DJ; Williams ME
    J Clin Invest; 1989 Nov; 84(5):1454-9. PubMed ID: 2509518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of the bcl-2 gene in Hodgkin's disease.
    Stetler-Stevenson M; Crush-Stanton S; Cossman J
    J Natl Cancer Inst; 1990 May; 82(10):855-8. PubMed ID: 2185367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCL-6 and other genomic alterations in non-Hodgkin's lymphoma (NHL).
    Butler M; Corbally N; Dervan PA; Carney DN
    Br J Cancer; 1997; 75(11):1641-5. PubMed ID: 9184180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AIDS-related non-Hodgkin's lymphomas: molecular genetics, viral infection and cytokine deregulation.
    Gaidano G; Pastore C; Gloghini A; Volpe G; Ghia P; Saglio G; Carbone A
    Acta Haematol; 1996; 95(3-4):193-8. PubMed ID: 8677742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of single and associated lesions of the Bcl-1, Bcl-2, Bcl-6, c-myc, p53 and p16 genes in B-cell non-Hodgkin's lymphomas: value of molecular analysis for a better assignment of the histologic subtype.
    García-Sanz R; Vargas Montero M; Gonzalez Díaz M; del Carmen M; Santos C; Balanzategui Echevarria A; Flores Corral T; Hernández Martín JM; Caballero Barrigón MD; San Miguel JF
    Haematologica; 1998 Mar; 83(3):209-16. PubMed ID: 9573674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53, c-myc p62 and proliferating cell nuclear antigen (PCNA) expression in non-Hodgkin's lymphomas.
    Korkolopoulou P; Oates J; Kittas C; Crocker J
    J Clin Pathol; 1994 Jan; 47(1):9-14. PubMed ID: 7907610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rearrangements of the BCL-6 gene in acquired immunodeficiency syndrome-associated non-Hodgkin's lymphoma: association with diffuse large-cell subtype.
    Gaidano G; Lo Coco F; Ye BH; Shibata D; Levine AM; Knowles DM; Dalla-Favera R
    Blood; 1994 Jul; 84(2):397-402. PubMed ID: 8025268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent alteration of MDM2 and p53 in the molecular progression of recurring non-Hodgkin's lymphoma.
    Møller MB; Nielsen O; Pedersen NT
    Histopathology; 2002 Oct; 41(4):322-30. PubMed ID: 12383214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcl-2 rearrangements with breakpoints in both vcr and mbr in non-Hodgkin's lymphomas and chronic lymphocytic leukaemia.
    Merup M; Spasokoukotskaja T; Einhorn S; Smith CI; Gahrton G; Juliusson G
    Br J Haematol; 1996 Mar; 92(3):647-52. PubMed ID: 8616030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bcl-2 oncogene in Hodgkin's disease arising in the setting of follicular non-Hodgkin's lymphoma.
    LeBrun DP; Ngan BY; Weiss LM; Huie P; Warnke RA; Cleary ML
    Blood; 1994 Jan; 83(1):223-30. PubMed ID: 8274737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The malignant lymphomas of Kenya: morphology, immunophenotype, and frequency of Epstein-Barr virus in 73 cases.
    Cool CD; Bitter MA
    Hum Pathol; 1997 Sep; 28(9):1026-33. PubMed ID: 9308726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogene rearrangement in non-Hodgkin's lymphoma with a 14q+ chromosome of unknown origin.
    Nakamine H; Masih AS; Chan WC; Sanger WG; Armitage JO; Weisenburger DD
    Leuk Lymphoma; 1993 May; 10(1-2):79-88. PubMed ID: 8374527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular pathogenesis of AIDS-associated non-Hodgkin's lymphoma.
    Shiramizu B; McGrath MS
    Hematol Oncol Clin North Am; 1991 Apr; 5(2):323-30. PubMed ID: 2022596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro establishment of AIDS-related lymphoma cell lines: phenotypic characterization, oncogene and tumor suppressor gene lesions, and heterogeneity in Epstein-Barr virus infection.
    Gaidano G; Parsa NZ; Tassi V; Della-Latta P; Chaganti RS; Knowles DM; Dalla-Favera R
    Leukemia; 1993 Oct; 7(10):1621-9. PubMed ID: 8412324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent c-myc oncogene activation and infrequent presence of Epstein-Barr virus genome in AIDS-associated lymphoma.
    Subar M; Neri A; Inghirami G; Knowles DM; Dalla-Favera R
    Blood; 1988 Aug; 72(2):667-71. PubMed ID: 2840989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.